ACE2 and COVID-19: The high burden of illness and high case-fatality ratio in patients with COVID-19 may be driven in part by the strong affinity of the virus for ACE2, leading to virus entry and multisystem illness in pulmonary, gut, renal, cardiac, and central nervous systems (16).